Article Details

Eisai Announces Publication of Post Hoc Analysis Data of LENVIMA® (lenvatinib) from Phase 3 ...

Retrieved on: 2021-04-29 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Eisai Announces Publication of Post Hoc Analysis Data of LENVIMA® (lenvatinib) from Phase 3 .... View article details on HISWAI: https://www.biospace.com/article/releases/eisai-announces-publication-of-post-hoc-analysis-data-of-lenvima-lenvatinib-from-phase-3-select-trial-in-certain-patients-with-differentiated-thyroid-cancer-in-the-european-journal-of-cancer/

Excerpt

"Analyses like these represent our commitment to continuing to explore, analyze and publish scientific findings for physicians and patients, alike, in ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up